CASE Op-Ed in Newsmax: Time for CFPB to Get Out of Consumers’ Way
The Time for the CFPB to Stop Merely Keeping Up Appearances Is Long Overdue The cost-of-living keeps rising. Following years...
CASE Op-Ed in DC Journal: Americans Won’t Be Thankful for Higher Canned Food Prices
November 21, 2023 In tough times or better days, Americans have always found much for which to be grateful....
CASE Hails GOP’s Pro-Consumer ‘Commitment to America’ as Good Medicine for the Economy
September 28, 2022 The GOP recently released their Commitment to America, a detailed plan to put America back on...
CASE Op-Ed – RealClearHealth: Biden Administration Is Using Inflation to Masquerade Their Drug Pricing Schemes
July 26, 2022 The midterms are less than five months away, and with President Biden’s approval numbers at a historic...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/